What Ensign Does & How It Makes Money (ENSG)
Updated October 2026 · reflects Ensign's latest reported financials
Operator of skilled nursing, senior living, and rehab facilities. It earns most of its revenue from patient care services at its skilled nursing and senior living facilities, plus ancillary services like pharmacy, diagnostics, and transportation.
How Ensign makes money
It earns most of its revenue from patient care services at its skilled nursing and senior living facilities, plus ancillary services like pharmacy, diagnostics, and transportation. Its Standard Bearer segment also collects rent by leasing post-acute care properties to healthcare operators.
What Ensign does
The Ensign Group is a U.S. operator of skilled nursing, senior living, and rehabilitative care facilities, headquartered in San Juan Capistrano, California, and incorporated in 1999. Its Skilled Services segment provides short- and long-term nursing care for the elderly and for patients with chronic conditions or prolonged illness. It also offers specialty care such as on-site dialysis, ventilator, cardiac, and pulmonary management, along with room and board, nutrition, social, and recreational services. The Standard Bearer segment owns post-acute care properties and leases them to healthcare operators, which adds a real-estate income stream. Ensign also offers ancillary services such as digital x-ray, ultrasound, electrocardiograms, respiratory care, long-term care pharmacy, patient transportation, and mobile diagnostics. Its facilities are in 16 states, including Texas, Arizona, Utah, Washington, and Colorado.
Products & services
- Skilled nursing care
- Rehabilitative therapy services
- Senior living communities
- Specialty care (dialysis, ventilator, cardiac, pulmonary)
- Standard Bearer post-acute property leasing
- Ancillary services (mobile diagnostics, long-term care pharmacy, patient transportation)
What is Ensign worth?
On an owner-earnings DCF, Ensign's most-likely value is about $243 versus a recent price near $172 (42% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$75) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
National Health Investors (NHI) · National HealthCare (NHC) · Encompass Health (EHC) · Healthcare Services (HCSG) · Omega Healthcare Investors (OHI)
TacticScale